BK virus treatment using donor immune cells after transplant
Part of Infections clinical trials.
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bladder/urinary symptoms like pain with urination or blood in urine, plus a positive BK virus test in the urine or blood
- You’ve had an allogeneic stem cell transplant (HSCT) or chemotherapy before starting the study
- Your age is 0.1 to 25 years, and you can provide consent (or a legal representative can)
- Your energy/function is good enough for the study (performance score above 30%)
- If you can get pregnant, you must have a negative pregnancy test and agree to reliable birth control
- A compatible donor is available who can provide immune cells that recognize BK virus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This study looks at how the immune system reacts to the BK virus in people who have had a kidney transplant. It may help doctors understand why some patients develop the virus in their blood and how to better manage it.
This early-phase (Phase 1) study tests an immune cell treatment (R-MVST) to help people whose immune system has been weakened by a past transplant and who keep getting viral infections reactivated or not responding well to standard treatment. It may help your body control viruses like EBV, CMV, adenovirus, or BK virus.
This Phase 1/2 study tests lab-made immune cells that specifically target BK virus in people whose BK infection keeps coming back or doesn’t improve. It may help by boosting the body’s ability to clear the virus, especially when standard antiviral treatments don’t work or can’t be tolerated.
This trial tests a new cell therapy (LB-DTK-BKV) for patients who developed a painful BK virus bladder infection after receiving a stem cell transplant and didn't improve with standard treatment. The therapy may help control the virus and reduce bleeding and pain.
This trial tests whether specially trained immune cells (virus-specific T cells) can safely treat stubborn viral infections after a stem cell transplant. It focuses on children and young adults who have not responded to standard antiviral treatments.
Hear when a new BK Polyomavirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.